. 2002 Oct;161(4):1207–1213. doi: 10.1016/S0002-9440(10)64397-0

Table 1.

Markers for LOH and MSI Analysis

Marker	Chromosomal location	Repeat type	Putative tumor suppressor gene(s)/remarks
D2S123	2p16-21	Dinucleotide	hMSH2; MSI consensus marker
D3S1478	3p21	Dinucleotide	FHIT; hMLH1
D3S2456	3p	Tetranucleotide	FHIT; hMLH1
D5S346	5q21	Dinucleotide	APC; MSI consensus marker
D5S107	5q11.2-q13.3	Dinucleotide	APC
D9S171	9p21	Dinucleotide	p14^ARF; p16^INK4A; p15^INK4B
D9S932	9p	Tetranucleotide	p14^ARF; p16^INK4A; p15^INK4B
D10S2491	10q23	Dinucleotide	PTEN (intragenic marker)
D14S68	14q24.3-q	Dinucleotide	frequently deleted region in Barrett carcinomas
D16S2624	16q22.1	Tetranucleotide	E-cadherin
P53 Alu	17p	Alu repeat	p53 (intragenic marker)
TP53	17p13.1	Dinucleotide	p53
D17S250	17q11.2-q12	Dinucleotide	BRCA1; MSI consensus marker
D18S64	18q21.32	Dinucleotide	DCC; DPC4/SMAD4; SMAD2
D18S474	18q	Dinucleotide	DCC; DPC4/SMAD4; SMAD2
D19S565	19p13.3	Dinucleotide	STK11/LKB1
D19S886	19p13.3	Dinucleotide	STK11/LKB1
D21S49	21q22.3	Dinucleotide	TFF1
BAT25	4q12	Mononucleotide	MSI consensus marker
BAT26	2p16	Mononucleotide	MSI consensus marker
BAT40	1p13.1	Mononucleotide	MSI consensus marker